Cboe Global Markets, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CBOE in the last 30 days.
See all $CBOE insider activity →Cboe Clear U.S. received SEC approval to expand its clearing capabilities to include binary securities options, alongside futures. This positions Cboe to support innovation across markets. The options are planned to list on Cboe Options Exchange and Robinhood in Q4 2026. Cboe Global Markets (CBOE) operates derivatives, equities, and FX markets.
Analysts made several calls on Friday. Roth initiated Natera and Guardant Health with buy ratings, targeting $475 and growth respectively. PhillipCapital upgraded SpaceX to buy with a $250 price target. Seaport reiterated Nvidia as sell due to competitive pressures. Barclays initiated Rush Street Interactive at overweight. Piper Sandler downgraded Deckers to underweight. Jefferies upgraded MSC Industrial to buy. Citizens initiated Microbot Medical at market outperform.
Morgan Stanley raised its price target for Cboe Global Markets (CBOE) to $450 from $358 and named it a Top Pick, citing SEC approval for new prediction markets as a significant revenue opportunity. The firm maintains an Overweight rating. According to the analyst, the approval removes a key hurdle and unlocks potential revenue not yet reflected in estimates.
Over the past 7 days, AlphAI's AI scored 23 news stories mentioning CBOE (Cboe Global Markets, Inc.). Coverage has skewed bullish: 19 bullish, 4 neutral, and 0 bearish.
Recent CBOE coverage spans financial news, regulation and corporate actions.
The approval enables CBOE to launch new binary options products, potentially increasing trading volumes and fee revenue.
Top‑pick status may boost price.
Analyst upgrade suggests bullish outlook for CBOE.
The buyback increase and dividend raise provide immediate support to the stock and may attract income-focused investors.
Positive outlook from sector rotation.
AlphAI scores every news story that mentions CBOE with an AI model for sentiment and relevance, and aggregates insider trades from Cboe Global Markets, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cboe Clear U.S. received SEC approval to expand its clearing capabilities to include binary securities options, alongside futures. This positions Cboe to support innovation across markets. The options are planned to list on Cboe Options Exchange and Robinhood in Q4 2026. Cboe Global Markets (CBOE) operates derivatives, equities, and FX markets.
2 min readAnalysts made several calls on Friday. Roth initiated Natera and Guardant Health with buy ratings, targeting $475 and growth respectively. PhillipCapital upgraded SpaceX to buy with a $250 price target. Seaport reiterated Nvidia as sell due to competitive pressures. Barclays initiated Rush Street Interactive at overweight. Piper Sandler downgraded Deckers to underweight. Jefferies upgraded MSC Industrial to buy. Citizens initiated Microbot Medical at market outperform.
2 min readMorgan Stanley raised its price target for Cboe Global Markets (CBOE) to $450 from $358 and named it a Top Pick, citing SEC approval for new prediction markets as a significant revenue opportunity. The firm maintains an Overweight rating. According to the analyst, the approval removes a key hurdle and unlocks potential revenue not yet reflected in estimates.
1 min readCboe Global Markets (CBOE) approved a $550M share buyback and a $0.86 Q4 2026 dividend, payable Dec 15 to shareholders of record Nov 30, according to the company.
1 min readCME Group (CME), Cboe Global Markets (CBOE), Intercontinental Exchange (ICE), and Nasdaq (NDAQ) are highlighted as top stocks in the Financial Services-Specialty group, benefiting from sector rotation out of AI stocks, according to Investor's Business Daily.
2 min readRBC Capital's Ashish Sabadra maintained a Hold rating on Cboe Global Markets (CBOE) with a $303.00 price target. Wells Fargo also gave a Hold, while TD Cowen kept a Buy. CBOE reported Q2 revenue of $1.44B and net profit of $353.1M, up from $1.17B and $235.1M last year.
1 min readCboe Global Markets (CBOE) extended trading hours for select equity and ETF options, adding pre-market (7:30–9:25 a.m. ET) and post-market (4:00–4:15 p.m. ET) sessions. The move covers options representing about 53% of 2023 year-to-date U.S.-listed options volume. Cboe aims to drive volume and fee growth in these sessions.
2 min readThe SEC approved Cboe Global Markets' proposal for binary options tied to KPIs of 23 companies, including Coinbase, Robinhood, and MARA. These cash-settled contracts allow investors to bet on specific financial or operating results. Robinhood may offer these products, with trading conditional on further regulatory approvals. The options settle based on SEC filings and have a fixed $1 payout if conditions are met.
3 min readNasdaq plans to introduce a 5-hour overnight trading session from 9 p.m. to 4 a.m. ET on Dec. 6, pending industry readiness and regulatory approval. The move aims to accommodate Asia-Pacific investors but raises concerns about liquidity and operational demands. Industry participants discussed the proposal at the WFIC 2026 panel, including representatives from Nasdaq, Cboe, Morgan Stanley, and others. The SEC has already approved a similar 23-hour schedule for Cboe EDGX.
2 min readCboe Global Markets will appoint Catherine Grover as its new HR chief on Nov. 16. Grover, a longtime PNC executive, will oversee workforce planning as the company pursues growth. CEO Craig Donohue linked the appointment to Cboe's expansion plans, emphasizing the need to attract and retain talent.
2 min read
